 | • レポートコード：QYR2104Z0317 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、退形成性乏突起星細胞腫のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線）、用途別市場規模（病院、がんセンター、手術センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・退形成性乏突起星細胞腫の市場動向 ・企業の競争状況、市場シェア ・退形成性乏突起星細胞腫の種類別市場規模（化学療法、放射線） ・退形成性乏突起星細胞腫の用途別市場規模（病院、がんセンター、手術センター） ・退形成性乏突起星細胞腫の北米市場規模2016-2027（アメリカ、カナダ） ・退形成性乏突起星細胞腫のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・退形成性乏突起星細胞腫のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・退形成性乏突起星細胞腫の中南米市場規模2016-2027（メキシコ、ブラジル） ・退形成性乏突起星細胞腫の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Tocagen、Shandong Lanjin Pharmaceuticals、Keryx Biopharmaceuticals、Insys Therapeutics、Rush University Medical Center） ・結論 |
Oligoastrocytomas is a part of a group of brain tumor called “gliomas”. Glioma tumor is originated in the brain or spine. Oligoastrocytomas contains both astrocytoma cells and oligodendroglioma. About 2.3% of the brain tumors reported are diagnosed as oligoastrocytomas. Oligoastrocytomas is divided into two parts, low grade and anaplastic. According to the WHO grading system, anaplastic oligoastrocytomas are usually identify as grade 1 and grade 2 but sometimes they appear to be grade 4. Anaplastic oligoastrocytomas can be characterized by high cellularity, conspicuous cytologic atypism, microvascular proliferation, mitotic activity and necrosis. Patients suffering from this condition show symptoms like headache, seizure and speech or motor changes. According to the American Brain Cancer Association, clinical trials for the treatment of this tumor are in process to minimize the recurrence rate of anaplastic oligoastocytoma caused after the surgical removal of tumor or chemotherapy and radiation therapy session.
Anaplastic oligoastrocytomas market is offers potential opportunities to cancer care industry. Factors contributing the growth of anaplastic oligoastrocytomas market are rising geriatric population, increasing incidence of anaplastic oligoastrocytomas and increasing pace of clinical trials for novel drug development. Moreover factors such as advancement in technology and innovations in diangositc techniques is expected to drive the growth of anaplastic oligoastrocytoma market over the forecast period. However, lack of specific treatment and critical diagnosis of anaplastic oligoastrocytoma is the major challenge for anaplastic oligoastrocytomas market.
Market Analysis and Insights: Global Anaplastic Oligoastrocytoma Market
The global Anaplastic Oligoastrocytoma market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anaplastic Oligoastrocytoma market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anaplastic Oligoastrocytoma market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anaplastic Oligoastrocytoma market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anaplastic Oligoastrocytoma market.
Global Anaplastic Oligoastrocytoma Scope and Market Size
Anaplastic Oligoastrocytoma market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anaplastic Oligoastrocytoma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Chemotherapy
Radiation
Segment by Application
Hospitals
Cancer Centers
Surgical Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Tocagen
Shandong Lanjin Pharmaceuticals
Keryx Biopharmaceuticals
Insys Therapeutics
Rush University Medical Center
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anaplastic Oligoastrocytoma Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Radiation
1.3 Market by Application
1.3.1 Global Anaplastic Oligoastrocytoma Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Cancer Centers
1.3.4 Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anaplastic Oligoastrocytoma Market Perspective (2016-2027)
2.2 Anaplastic Oligoastrocytoma Growth Trends by Regions
2.2.1 Anaplastic Oligoastrocytoma Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anaplastic Oligoastrocytoma Historic Market Share by Regions (2016-2021)
2.2.3 Anaplastic Oligoastrocytoma Forecasted Market Size by Regions (2022-2027)
2.3 Anaplastic Oligoastrocytoma Industry Dynamic
2.3.1 Anaplastic Oligoastrocytoma Market Trends
2.3.2 Anaplastic Oligoastrocytoma Market Drivers
2.3.3 Anaplastic Oligoastrocytoma Market Challenges
2.3.4 Anaplastic Oligoastrocytoma Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anaplastic Oligoastrocytoma Players by Revenue
3.1.1 Global Top Anaplastic Oligoastrocytoma Players by Revenue (2016-2021)
3.1.2 Global Anaplastic Oligoastrocytoma Revenue Market Share by Players (2016-2021)
3.2 Global Anaplastic Oligoastrocytoma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anaplastic Oligoastrocytoma Revenue
3.4 Global Anaplastic Oligoastrocytoma Market Concentration Ratio
3.4.1 Global Anaplastic Oligoastrocytoma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anaplastic Oligoastrocytoma Revenue in 2020
3.5 Anaplastic Oligoastrocytoma Key Players Head office and Area Served
3.6 Key Players Anaplastic Oligoastrocytoma Product Solution and Service
3.7 Date of Enter into Anaplastic Oligoastrocytoma Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anaplastic Oligoastrocytoma Breakdown Data by Type
4.1 Global Anaplastic Oligoastrocytoma Historic Market Size by Type (2016-2021)
4.2 Global Anaplastic Oligoastrocytoma Forecasted Market Size by Type (2022-2027)
5 Anaplastic Oligoastrocytoma Breakdown Data by Application
5.1 Global Anaplastic Oligoastrocytoma Historic Market Size by Application (2016-2021)
5.2 Global Anaplastic Oligoastrocytoma Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Anaplastic Oligoastrocytoma Market Size (2016-2027)
6.2 North America Anaplastic Oligoastrocytoma Market Size by Type
6.2.1 North America Anaplastic Oligoastrocytoma Market Size by Type (2016-2021)
6.2.2 North America Anaplastic Oligoastrocytoma Market Size by Type (2022-2027)
6.2.3 North America Anaplastic Oligoastrocytoma Market Size by Type (2016-2027)
6.3 North America Anaplastic Oligoastrocytoma Market Size by Application
6.3.1 North America Anaplastic Oligoastrocytoma Market Size by Application (2016-2021)
6.3.2 North America Anaplastic Oligoastrocytoma Market Size by Application (2022-2027)
6.3.3 North America Anaplastic Oligoastrocytoma Market Size by Application (2016-2027)
6.4 North America Anaplastic Oligoastrocytoma Market Size by Country
6.4.1 North America Anaplastic Oligoastrocytoma Market Size by Country (2016-2021)
6.4.2 North America Anaplastic Oligoastrocytoma Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Anaplastic Oligoastrocytoma Market Size (2016-2027)
7.2 Europe Anaplastic Oligoastrocytoma Market Size by Type
7.2.1 Europe Anaplastic Oligoastrocytoma Market Size by Type (2016-2021)
7.2.2 Europe Anaplastic Oligoastrocytoma Market Size by Type (2022-2027)
7.2.3 Europe Anaplastic Oligoastrocytoma Market Size by Type (2016-2027)
7.3 Europe Anaplastic Oligoastrocytoma Market Size by Application
7.3.1 Europe Anaplastic Oligoastrocytoma Market Size by Application (2016-2021)
7.3.2 Europe Anaplastic Oligoastrocytoma Market Size by Application (2022-2027)
7.3.3 Europe Anaplastic Oligoastrocytoma Market Size by Application (2016-2027)
7.4 Europe Anaplastic Oligoastrocytoma Market Size by Country
7.4.1 Europe Anaplastic Oligoastrocytoma Market Size by Country (2016-2021)
7.4.2 Europe Anaplastic Oligoastrocytoma Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Anaplastic Oligoastrocytoma Market Size (2016-2027)
8.2 Asia-Pacific Anaplastic Oligoastrocytoma Market Size by Type
8.2.1 Asia-Pacific Anaplastic Oligoastrocytoma Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anaplastic Oligoastrocytoma Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anaplastic Oligoastrocytoma Market Size by Type (2016-2027)
8.3 Asia-Pacific Anaplastic Oligoastrocytoma Market Size by Application
8.3.1 Asia-Pacific Anaplastic Oligoastrocytoma Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anaplastic Oligoastrocytoma Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anaplastic Oligoastrocytoma Market Size by Application (2016-2027)
8.4 Asia-Pacific Anaplastic Oligoastrocytoma Market Size by Region
8.4.1 Asia-Pacific Anaplastic Oligoastrocytoma Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anaplastic Oligoastrocytoma Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anaplastic Oligoastrocytoma Market Size (2016-2027)
9.2 Latin America Anaplastic Oligoastrocytoma Market Size by Type
9.2.1 Latin America Anaplastic Oligoastrocytoma Market Size by Type (2016-2021)
9.2.2 Latin America Anaplastic Oligoastrocytoma Market Size by Type (2022-2027)
9.2.3 Latin America Anaplastic Oligoastrocytoma Market Size by Type (2016-2027)
9.3 Latin America Anaplastic Oligoastrocytoma Market Size by Application
9.3.1 Latin America Anaplastic Oligoastrocytoma Market Size by Application (2016-2021)
9.3.2 Latin America Anaplastic Oligoastrocytoma Market Size by Application (2022-2027)
9.3.3 Latin America Anaplastic Oligoastrocytoma Market Size by Application (2016-2027)
9.4 Latin America Anaplastic Oligoastrocytoma Market Size by Country
9.4.1 Latin America Anaplastic Oligoastrocytoma Market Size by Country (2016-2021)
9.4.2 Latin America Anaplastic Oligoastrocytoma Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anaplastic Oligoastrocytoma Market Size (2016-2027)
10.2 Middle East & Africa Anaplastic Oligoastrocytoma Market Size by Type
10.2.1 Middle East & Africa Anaplastic Oligoastrocytoma Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anaplastic Oligoastrocytoma Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anaplastic Oligoastrocytoma Market Size by Type (2016-2027)
10.3 Middle East & Africa Anaplastic Oligoastrocytoma Market Size by Application
10.3.1 Middle East & Africa Anaplastic Oligoastrocytoma Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anaplastic Oligoastrocytoma Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anaplastic Oligoastrocytoma Market Size by Application (2016-2027)
10.4 Middle East & Africa Anaplastic Oligoastrocytoma Market Size by Country
10.4.1 Middle East & Africa Anaplastic Oligoastrocytoma Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anaplastic Oligoastrocytoma Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Tocagen
11.1.1 Tocagen Company Details
11.1.2 Tocagen Business Overview
11.1.3 Tocagen Anaplastic Oligoastrocytoma Introduction
11.1.4 Tocagen Revenue in Anaplastic Oligoastrocytoma Business (2016-2021)
11.1.5 Tocagen Recent Development
11.2 Shandong Lanjin Pharmaceuticals
11.2.1 Shandong Lanjin Pharmaceuticals Company Details
11.2.2 Shandong Lanjin Pharmaceuticals Business Overview
11.2.3 Shandong Lanjin Pharmaceuticals Anaplastic Oligoastrocytoma Introduction
11.2.4 Shandong Lanjin Pharmaceuticals Revenue in Anaplastic Oligoastrocytoma Business (2016-2021)
11.2.5 Shandong Lanjin Pharmaceuticals Recent Development
11.3 Keryx Biopharmaceuticals
11.3.1 Keryx Biopharmaceuticals Company Details
11.3.2 Keryx Biopharmaceuticals Business Overview
11.3.3 Keryx Biopharmaceuticals Anaplastic Oligoastrocytoma Introduction
11.3.4 Keryx Biopharmaceuticals Revenue in Anaplastic Oligoastrocytoma Business (2016-2021)
11.3.5 Keryx Biopharmaceuticals Recent Development
11.4 Insys Therapeutics
11.4.1 Insys Therapeutics Company Details
11.4.2 Insys Therapeutics Business Overview
11.4.3 Insys Therapeutics Anaplastic Oligoastrocytoma Introduction
11.4.4 Insys Therapeutics Revenue in Anaplastic Oligoastrocytoma Business (2016-2021)
11.4.5 Insys Therapeutics Recent Development
11.5 Rush University Medical Center
11.5.1 Rush University Medical Center Company Details
11.5.2 Rush University Medical Center Business Overview
11.5.3 Rush University Medical Center Anaplastic Oligoastrocytoma Introduction
11.5.4 Rush University Medical Center Revenue in Anaplastic Oligoastrocytoma Business (2016-2021)
11.5.5 Rush University Medical Center Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Anaplastic Oligoastrocytoma Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiation
Table 4. Global Anaplastic Oligoastrocytoma Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Anaplastic Oligoastrocytoma Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Anaplastic Oligoastrocytoma Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Anaplastic Oligoastrocytoma Market Share by Regions (2016-2021)
Table 8. Global Anaplastic Oligoastrocytoma Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Anaplastic Oligoastrocytoma Market Share by Regions (2022-2027)
Table 10. Anaplastic Oligoastrocytoma Market Trends
Table 11. Anaplastic Oligoastrocytoma Market Drivers
Table 12. Anaplastic Oligoastrocytoma Market Challenges
Table 13. Anaplastic Oligoastrocytoma Market Restraints
Table 14. Global Anaplastic Oligoastrocytoma Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Anaplastic Oligoastrocytoma Market Share by Players (2016-2021)
Table 16. Global Top Anaplastic Oligoastrocytoma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anaplastic Oligoastrocytoma as of 2020)
Table 17. Ranking of Global Top Anaplastic Oligoastrocytoma Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Anaplastic Oligoastrocytoma Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Anaplastic Oligoastrocytoma Product Solution and Service
Table 21. Date of Enter into Anaplastic Oligoastrocytoma Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anaplastic Oligoastrocytoma Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Anaplastic Oligoastrocytoma Revenue Market Share by Type (2016-2021)
Table 25. Global Anaplastic Oligoastrocytoma Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Anaplastic Oligoastrocytoma Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Anaplastic Oligoastrocytoma Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Anaplastic Oligoastrocytoma Revenue Market Share by Application (2016-2021)
Table 29. Global Anaplastic Oligoastrocytoma Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Anaplastic Oligoastrocytoma Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Anaplastic Oligoastrocytoma Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Anaplastic Oligoastrocytoma Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Anaplastic Oligoastrocytoma Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Anaplastic Oligoastrocytoma Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Anaplastic Oligoastrocytoma Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Anaplastic Oligoastrocytoma Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Anaplastic Oligoastrocytoma Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Anaplastic Oligoastrocytoma Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Anaplastic Oligoastrocytoma Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Anaplastic Oligoastrocytoma Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Anaplastic Oligoastrocytoma Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Anaplastic Oligoastrocytoma Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Anaplastic Oligoastrocytoma Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Anaplastic Oligoastrocytoma Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Anaplastic Oligoastrocytoma Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Anaplastic Oligoastrocytoma Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Anaplastic Oligoastrocytoma Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Anaplastic Oligoastrocytoma Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Anaplastic Oligoastrocytoma Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Anaplastic Oligoastrocytoma Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Anaplastic Oligoastrocytoma Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Anaplastic Oligoastrocytoma Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Anaplastic Oligoastrocytoma Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Anaplastic Oligoastrocytoma Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Anaplastic Oligoastrocytoma Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Anaplastic Oligoastrocytoma Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Anaplastic Oligoastrocytoma Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Anaplastic Oligoastrocytoma Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Anaplastic Oligoastrocytoma Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Anaplastic Oligoastrocytoma Market Size by Country (2022-2027) & (US$ Million)
Table 61. Tocagen Company Details
Table 62. Tocagen Business Overview
Table 63. Tocagen Anaplastic Oligoastrocytoma Product
Table 64. Tocagen Revenue in Anaplastic Oligoastrocytoma Business (2016-2021) & (US$ Million)
Table 65. Tocagen Recent Development
Table 66. Shandong Lanjin Pharmaceuticals Company Details
Table 67. Shandong Lanjin Pharmaceuticals Business Overview
Table 68. Shandong Lanjin Pharmaceuticals Anaplastic Oligoastrocytoma Product
Table 69. Shandong Lanjin Pharmaceuticals Revenue in Anaplastic Oligoastrocytoma Business (2016-2021) & (US$ Million)
Table 70. Shandong Lanjin Pharmaceuticals Recent Development
Table 71. Keryx Biopharmaceuticals Company Details
Table 72. Keryx Biopharmaceuticals Business Overview
Table 73. Keryx Biopharmaceuticals Anaplastic Oligoastrocytoma Product
Table 74. Keryx Biopharmaceuticals Revenue in Anaplastic Oligoastrocytoma Business (2016-2021) & (US$ Million)
Table 75. Keryx Biopharmaceuticals Recent Development
Table 76. Insys Therapeutics Company Details
Table 77. Insys Therapeutics Business Overview
Table 78. Insys Therapeutics Anaplastic Oligoastrocytoma Product
Table 79. Insys Therapeutics Revenue in Anaplastic Oligoastrocytoma Business (2016-2021) & (US$ Million)
Table 80. Insys Therapeutics Recent Development
Table 81. Rush University Medical Center Company Details
Table 82. Rush University Medical Center Business Overview
Table 83. Rush University Medical Center Anaplastic Oligoastrocytoma Product
Table 84. Rush University Medical Center Revenue in Anaplastic Oligoastrocytoma Business (2016-2021) & (US$ Million)
Table 85. Rush University Medical Center Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anaplastic Oligoastrocytoma Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Radiation Features
Figure 4. Global Anaplastic Oligoastrocytoma Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Cancer Centers Case Studies
Figure 7. Surgical Centers Case Studies
Figure 8. Anaplastic Oligoastrocytoma Report Years Considered
Figure 9. Global Anaplastic Oligoastrocytoma Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Anaplastic Oligoastrocytoma Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Anaplastic Oligoastrocytoma Market Share by Regions: 2020 VS 2027
Figure 12. Global Anaplastic Oligoastrocytoma Market Share by Regions (2022-2027)
Figure 13. Global Anaplastic Oligoastrocytoma Market Share by Players in 2020
Figure 14. Global Top Anaplastic Oligoastrocytoma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anaplastic Oligoastrocytoma as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Anaplastic Oligoastrocytoma Revenue in 2020
Figure 16. Global Anaplastic Oligoastrocytoma Revenue Market Share by Type (2016-2021)
Figure 17. Global Anaplastic Oligoastrocytoma Revenue Market Share by Type (2022-2027)
Figure 18. North America Anaplastic Oligoastrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Anaplastic Oligoastrocytoma Market Share by Type (2016-2027)
Figure 20. North America Anaplastic Oligoastrocytoma Market Share by Application (2016-2027)
Figure 21. North America Anaplastic Oligoastrocytoma Market Share by Country (2016-2027)
Figure 22. United States Anaplastic Oligoastrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Anaplastic Oligoastrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Anaplastic Oligoastrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Anaplastic Oligoastrocytoma Market Share by Type (2016-2027)
Figure 26. Europe Anaplastic Oligoastrocytoma Market Share by Application (2016-2027)
Figure 27. Europe Anaplastic Oligoastrocytoma Market Share by Country (2016-2027)
Figure 28. Germany Anaplastic Oligoastrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Anaplastic Oligoastrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Anaplastic Oligoastrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Anaplastic Oligoastrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Anaplastic Oligoastrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Anaplastic Oligoastrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Anaplastic Oligoastrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Anaplastic Oligoastrocytoma Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Anaplastic Oligoastrocytoma Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Anaplastic Oligoastrocytoma Market Share by Region (2016-2027)
Figure 38. China Anaplastic Oligoastrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Anaplastic Oligoastrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Anaplastic Oligoastrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Anaplastic Oligoastrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Anaplastic Oligoastrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Anaplastic Oligoastrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Anaplastic Oligoastrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Anaplastic Oligoastrocytoma Market Share by Type (2016-2027)
Figure 46. Latin America Anaplastic Oligoastrocytoma Market Share by Application (2016-2027)
Figure 47. Latin America Anaplastic Oligoastrocytoma Market Share by Country (2016-2027)
Figure 48. Mexico Anaplastic Oligoastrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Anaplastic Oligoastrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Anaplastic Oligoastrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Anaplastic Oligoastrocytoma Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Anaplastic Oligoastrocytoma Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Anaplastic Oligoastrocytoma Market Share by Country (2016-2027)
Figure 54. Turkey Anaplastic Oligoastrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Anaplastic Oligoastrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Anaplastic Oligoastrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Tocagen Revenue Growth Rate in Anaplastic Oligoastrocytoma Business (2016-2021)
Figure 58. Shandong Lanjin Pharmaceuticals Revenue Growth Rate in Anaplastic Oligoastrocytoma Business (2016-2021)
Figure 59. Keryx Biopharmaceuticals Revenue Growth Rate in Anaplastic Oligoastrocytoma Business (2016-2021)
Figure 60. Insys Therapeutics Revenue Growth Rate in Anaplastic Oligoastrocytoma Business (2016-2021)
Figure 61. Rush University Medical Center Revenue Growth Rate in Anaplastic Oligoastrocytoma Business (2016-2021)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
世界の退形成性星細胞腫治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anaplastic Astrocytoma Treatment Market The global Anaplastic Astrocytoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…- 世界の成人悪性神経膠腫治療市場規模・現状・予測（2021年-2027年） Glioma is a broad category of brain and spinal cord tumors that come from glial cells brain cells that support nerve cells.The symptoms, prognosis, and treatment of a glioma depend on the person’s age, the exact type of tumor, and the location of the tumor within the brain. Market Analysis and Insig…
- 世界の病院・外来診療センター市場規模・現状・予測（2021年-2027年） Hospitals and outpatient centers are medical facilities that provide diagnostic and medical treatment to patients with a wide range of medical conditions. Outpatient care centers offer medical care or treatment that does not require any overnight stay in a hospital or medical facility. Outpatient ca…
- 世界の化学療法誘発性貧血市場規模・現状・予測（2021年-2027年） Anaemia is a frequent complication of malignancy and is aggravated by chemotherapy. The key factor contributing to the growth of the global chemotherapy induced anemia market is the increase in the occurrence of cancer and anemia among geriatric patients. Market Analysis and Insights: Global Chemoth…
- 世界の子宮内膜癌市場規模・現状・予測（2021年-2027年） Endometrial cancer is a cancer that arises from the endometrium (the lining of the uterus or womb). It is the result of the abnormal growth of cells that have the ability to invade or spread to other parts of the body. The first sign is most often vaginal bleeding not associated with a menstrual per…